MDxHealth (MDXH) Cash from Financing Activities (2021 - 2026)

MDxHealth (MDXH) has 5 years of Cash from Financing Activities data on file, last reported at $16.1 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 25.0% year-over-year to $16.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.5 million (up 0.71% YoY) and the FY2025 annual result came in at $3.0 million, down 93.35% from the prior year.
• Cash from Financing Activities advanced to $16.1 million in Q1 2026 per MDXH's latest filing, from $8.1 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $33.6 million in Q3 2024, with the low at -$814000.0 in Q1 2022.
• Average Cash from Financing Activities over 4 years is $11.0 million, with a median of $9.0 million recorded in 2025.
• Year-over-year, Cash from Financing Activities slumped 75.81% in 2025 and fell 25.0% in 2026.
• MDxHealth's Cash from Financing Activities stood at -$799000.0 in 2022, then jumped by 210.64% to $884000.0 in 2024, then surged by 818.33% to $8.1 million in 2025, then soared by 98.51% to $16.1 million in 2026.
• Business Quant data shows MDXH's Cash from Financing Activities at $16.1 million in Q1 2026, $8.1 million in Q3 2025, and $9.8 million in Q2 2025.